Consejo Superior de Investigaciones Cientificas:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Consejo Superior de Investigaciones Cientificas - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9404
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Consejo Superior de Investigaciones Cientificas (CSIC) is a research institute that offers research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management of infrastructures and large facilities, and others. Its scientific areas include humanities and social sciences, biology and biomedicine, natural resources, agricultural sciences, physical science and technologies, materials science and technology, food science and technology, and chemical science and technology. The institute also offers research training, post graduate courses, and predoctoral contracts. CSIC is headquartered in Madrid, Spain.

Consejo Superior de Investigaciones Cientificas – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Inmunotek Enters into Agreement with CIB-CSIC 10
Licensing Agreements 11
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
HIVACAT Enters into Licensing Agreement with CSIC 13
Consejo Superior de Investigaciones Cientificas – Key Competitors 14
Consejo Superior de Investigaciones Cientificas – Key Employees 15
Consejo Superior de Investigaciones Cientificas – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Nov 17, 2017: Researchers of the CSIC discover that a group of lymphocytes activates a response capable of destroying tumors 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Key Facts 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Consejo Superior de Investigaciones Cientificas, Deals By Therapy Area, 2012 to YTD 2018 8
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Inmunotek Enters into Agreement with CIB-CSIC 10
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 11
Janus Developments Enters Into Licensing Agreement With UB, CSIC And UAB 12
HIVACAT Enters into Licensing Agreement with CSIC 13
Consejo Superior de Investigaciones Cientificas, Key Competitors 14
Consejo Superior de Investigaciones Cientificas, Key Employees 15

List of Figures
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Consejo Superior de Investigaciones Cientificas, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Consejo Superior de Investigaciones Cientificas:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aspen Pharmacare Holdings Ltd (APN)-製薬・医療分野:企業M&A・提携分析
    Summary Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions. The company also manufactures infant nutritionals and consumer healthcare products in selected territories. Its manufacturi …
  • Sun Life Hong Kong Limited:企業の戦略・SWOT・財務分析
    Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report Summary Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • OpenHydro Group Limited-エネルギー分野:企業M&A・提携分析
    Summary OpenHydro Group Limited (OpenHydro), a subsidiary of DCNS S.A. designs and manufactures marine turbines for generating renewable energy from tidal streams. The company offers installation and maintenance services for the construction of tidal farms using its Open-Centre Turbine technology. T …
  • Novatek (NVTK):企業の財務・戦略的SWOT分析
    Novatek (NVTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Oncodesign SA (ALONC):企業の財務・戦略的SWOT分析
    Summary Oncodesign SA (Oncodesign) is a biopharmaceutical company, specializing in precision medicine offers drug discovery and pharmacological evaluation services for cancer. Its service offerings include integrated drug discovery; metabolic and pharmacokinetic characteristics of chemical and biolo …
  • Arizona Public Service Co:電力:M&Aディール及び事業提携情報
    Summary Arizona Public Service Co (APS), a subsidiary of Pinnacle West Capital Corporation, is an energy utility that generates, procures, transmits, and distributes electricity. The company generates electricity from coal, nuclear, gas, oil, and renewable sources such as solar, wind, geothermal, bi …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • Penumbra Inc (PEN):医療機器:M&Aディール及び事業提携情報
    Summary Penumbra Inc (Penumbra) is a medical device company that designs, develops, manufactures and markets neuro devices and peripheral devices. The company’s neurovascular mechanical thrombectomy systems include revascularization device, reperfusion catheters, distal delivery catheters, neuro eva …
  • OAO Gazprom:企業の戦略・SWOT・財務情報
    OAO Gazprom - Strategy, SWOT and Corporate Finance Report Summary OAO Gazprom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Pioneer Natural Resources Company:企業の戦略・SWOT・財務情報
    Pioneer Natural Resources Company - Strategy, SWOT and Corporate Finance Report Summary Pioneer Natural Resources Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • SCIO Health Analytics:企業の戦略的SWOT分析
    SCIO Health Analytics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • American Equity Investment Life Holding Company:企業の戦略・SWOT・財務情報
    American Equity Investment Life Holding Company - Strategy, SWOT and Corporate Finance Report Summary American Equity Investment Life Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Ackermans & Van Haaren NV:戦略・SWOT・企業財務分析
    Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report Summary Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Liebherr-International AG:企業の戦略・SWOT・財務分析
    Liebherr-International AG - Strategy, SWOT and Corporate Finance Report Summary Liebherr-International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SK Telecom Co., Ltd.:企業の戦略・SWOT・財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • 7-Eleven Inc:企業のM&A・事業提携・投資動向
    7-Eleven Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 7-Eleven Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Menlo Therapeutics Inc (MNLO):製薬・医療:M&Aディール及び事業提携情報
    Summary Menlo Therapeutics Inc (Menlo Therapeutics) formerly Tigercat Pharma Inc, is a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions such as psoriasis and prurigo nodularis, a …
  • Schaffer Corporation Limited (SFC):企業の財務・戦略的SWOT分析
    Schaffer Corporation Limited (SFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Santen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Santen Inc (Santen), a subsidiary of Santen Pharmaceutical Co Ltd, is a pharmaceutical company that develops, manufactures and markets ophthalmic products. The company offers products in therapeutic areas of retinal disorders, glaucoma and corneal diseases. It conducts diagnosis on uveitis c …
  • Pioneer Energy Services Corp (PES):企業の財務・戦略的SWOT分析
    Pioneer Energy Services Corp (PES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆